TY  - JOUR
AU  - Lucena-Cacace, Antonio
AU  - Otero-Albiol, Daniel
AU  - Jimenez-Garcia, Manuel P.
AU  - Peinado-Serrano, Javier
AU  - Carnero, Amancio
PY  - 2017
DO  - 10.18632/oncotarget.20577
UR  - http://hdl.handle.net/10668/19442
T2  - Oncotarget
AB  - Gliomas are the most prevalent primary malignant brain tumors associated with poor prognosis. NAMPT, a rate-limiting enzyme that boosts the nicotinamide adenine dinucleotide (NAD) regeneration in the salvage pathway, is commonly expressed in these...
LA  - en
PB  - Impact journals llc
KW  - NAMPT
KW  - cancer initiating cell
KW  - gene signature
KW  - glioma
KW  - glioblastoma
KW  - Nicotinamide phosphoribosyltransferase
KW  - Heterogeneity implications
KW  - Glioblastoma-multiforme
KW  - Anaplastic glioma
KW  - Target therapies
KW  - Cell-death
KW  - Metabolism
KW  - Biology
KW  - Nad(+)
KW  - Subtypes
TI  - NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
TY  - research article
VL  - 8
ER  -